New Sale

Date : 09/06/2006 @ 3:54AM
Source : RNS Non regulatory
Stock : Premier Bionics Ltd (PBI)
Quote : 13.51  0.06 (0.45%) @ 5:19PM
Pitney Bowes share price Chart

New Sale


Premier Bionics Limited
06 September 2006




          Premier Bionics Limited ("Premier Bionics" or the "Company")

            Chinese demand increases for medical training technology


Premier Bionics' wholly owned subsidiary, Medic Vision Pty Ltd ("Medic Vision")
today announced another significant breakthrough in China for its world-leading
medical training technology.


The Australian company said it had sold four of its cannulation simulators -
used for teaching intravenous techniques to nurses, doctors and paramedics - to
the Southwest Hospital in Chongqing, China, for approximately A$150,000.


Medic Vision Chief Executive Officer, Mr Ross Horley, commented, "this is a
further, significant step forward in our penetration into China for the
provision of simulation for medical skills training."


"The Southwest Hospital is the largest hospital in the municipality, treating
approximately one million outpatients per year," he said.


The Chongqing sales success is the Melbourne-based Company's third major
overseas sales contract in as many months, and follows:


O  the purchase of the cannulation simulator by Hong Kong's Professional
   Medical Centre, a leading education agency that trains all tiers of health
   professionals throughout the country,

O  an agreement with global medical training products group, the US-based
   Immersion Medical, to supply maintenance and support services, and

O  a contract to design innovative training technology for the new
   state-of-the-art medical and surgical skills training facility for the Royal
   College of Surgeons of England, in London.


Intravenous cannulation is the process of placing a needle into a vein for the
injection of fluid and medications.


Medic Vision's simulator enables nurses, doctors and other medical professionals
to practice the delicate procedure by projecting an image of the needle and a '
patient's vein' onto a screen in virtual reality.


Earlier this year Medic Vision announced an A$850,000 contract to provide
computer-based surgical simulation and consulting services to the same hospital.


Media contacts:

Ross Horley                             Peter Gill

Managing Director, Medic Vision         Field Public Relations

+61 3 8508 8288 / 0400 209 899          61 8 8234 9555 / +61 417 784 059


Mr Peter Marks

Chairman, Premier Bionics

+61 3 9824 8166

Background on Premier Bionics

Premier Bionics was formed in December 2001 to invest in advanced,
Australian-based research in medical devices and diagnostics. The Company listed
on the Australian Stock Exchange (ASX: PBI) in May 2002 and listed on AIM (AIM:
PBI) in November 2005.


See www.premierbionics.com.au for more details.

Background on Medic Vision

Medic Vision is a technology based company specialising in the application of
technology for surgical and medical skills training.  Medic Vision provides
consulting services in the development of skills training centres as well as
developing and deploying computer-based surgical and medical high fidelity
simulators.


See www.medicvision.com.au for more details


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NRAKGGGLNVZGVZG

Pitney Bowes (NYSE:PBI)
Historical Stock Chart

1 Year : From May 2011 to May 2012

Click Here for more Pitney Bowes Charts.

Pitney Bowes (NYSE:PBI)
Intraday Stock Chart

Today : Wednesday 16 May 2012

Click Here for more Pitney Bowes Charts.


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Affiliate Scheme
Copyright 1999-2011 ADVFN PLC. Copyright Notice & Privacy Policy :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
34 site:2us 120516 18:01